placeholder image

Q. Liao All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study
  • Contact

    full name

  • Q. Liao
  • Quick Info

    Publications

    Collaboration